synchrotron X-ray Crystallography in drug Discovery
We highlight a study conducted by the AstraZeneca team on synchrotron X-ray crystallography in drug discovery (Käck & Sjögren, 2024).
fragment-based drug discovery
-
-
Crystallographic Fragment Screening In Drug Discovery: Background & Advantages
Technical developments have made crystallographic fragment screening the most effective method for screening fragment libraries. Here, we provide a brief overview of the method and its requirements.
-
Early Drug Discovery Services: Why Do You Need A CRO?
We discuss the the early drug discovery services market and highlight the integrated drug discovery CRO services provided by SARomics Biostructures.
-
WAC™ Fragment screening technology: Principles & Advantages
In this article, we discuss weak affinity chromatography (WAC™), the proprietary fragment screening technique jointly owned by SARomics Biostructures and Red Glead Discovery.
-
How to Choose A Library for Screening?
In this third post on structural biology and structure-based drug design we discuss methods and benefits of fragment-based lead discovery
